(Q37216578)

19 August 2017

1 reference

title

Development of diabetic cardiomyopathy and the kallikrein-kinin system--new insights from B1 and B2 receptor signaling (English)

1 reference

19 August 2017

1 reference

diabetic cardiomyopathy

1 reference

1

Carsten Tschöpe

1 reference

19 August 2017

Dirk Westermann

2

1 reference

19 August 2017

publication date

1 June 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

389

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

707-711

1 reference

Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

In vivo B1 kinin-receptor upregulation. Evidence for involvement of protein kinases and nuclear factor kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

21 January 2018

Diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

p38 stress-activated protein kinase inhibitor reverses bradykinin B(1) receptor-mediated component of inflammatory hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the brady

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Functional properties of failing human ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Association between kinin B(1) receptor expression and leukocyte trafficking across mouse mesenteric postcapillary venules

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Pharmacological enhancement of the kallikrein-kinin system promotes anti-fibrotic responses in human mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

The cardiovascular influence of interleukin-1 beta on the expression of bradykinin B1 and B2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Further pharmacological evidence of nuclear factor-kappa B pathway involvement in bradykinin B1 receptor-sensitized responses in human umbilical vein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Bradykinin increases intracellular calcium levels in rat testis peritubular cells via the B2 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2008.082

21 January 2018

Identifiers

DOI

10.1515/BC.2008.082

1 reference

19 August 2017

1 reference